Replies to post #488829 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

one month we claim LP is enriching herself through NWBO and 'true ups' and the next month we are back to claiming a wholly incongruent position that LP is enriching herself through Toucan. NWBO is either the cash cow or it isn't. You can't argue both sides. Ultimately I believe some shareholders have no issues jumping to wholly incongruent positions so long as it accomplishes the goal of putting nwbo in a bad light. I personally don't believe in either of these nonsensical positions and that is why I'm invested in nwbo.

have a good one PM

[Horseb4CarT]

As I’ve opined previously, the focus is on the goal of DCVax approval, and although management may care about common shareholders, we are secondary at best and somewhat fungible (proper usage?) if deemed necessary to advance the primary goal.

I’ve long felt that way and accepted the prospect of some collateral damage.

In any event I think we are past the collateral damage phase unless we get a big dilutive financing, which I think has been avoided recently.

[OPennyS]

10/5/2020

Ms. Powers continued. "We are also very grateful to our shareholders for their patience and support, which has made all this possible."